GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
25. Juni 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
21. Juni 2024 08:00 ET
|
Genetic Technologies Ltd
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Genetic Technologies Expands Operational Capacity in North America
18. Juni 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Expands Operational Capacity in North America
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
05. Juni 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention
09. November 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health,...
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
29. September 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
GENE Momentum building - a year in review
30. August 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in guideline driven genomics-based tests in health,...
GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians
18. Juli 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 18, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
GeneType Risk Assessment Test onboarding in 16 clinics
01. Juli 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...